Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
2,825,612
-
Shares change
-
+2,797,012
-
Total reported value, excl. options
-
$23,559,344
-
Value change
-
+$23,320,809
-
Put/Call ratio
-
11.01%
-
Number of buys
-
69
-
Price
-
$8.34
Significant Holders of bluebird bio, Inc. - COM NEW (BLUE) as of Q4 2024
80 filings reported holding BLUE - bluebird bio, Inc. - COM NEW as of Q4 2024.
bluebird bio, Inc. - COM NEW (BLUE) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,825,612 shares
.
Largest 10 shareholders include BlackRock, Inc. (708,669 shares), VANGUARD GROUP INC (525,414 shares), GEODE CAPITAL MANAGEMENT, LLC (233,514 shares), STATE STREET CORP (197,921 shares), UBS Group AG (106,302 shares), NATIONAL BANK OF CANADA /FI/ (81,704 shares), NORTHERN TRUST CORP (81,700 shares), Avidity Partners Management LP (81,555 shares), Lion Point Capital, LP (78,912 shares), and PFM Health Sciences, LP (75,758 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.